(Q47276347)

13 January 2018

title

No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis (English)

1 reference

13 January 2018

author name string

J N P Zwemmer

1

1 reference

13 January 2018

T van Veen

2

1 reference

13 January 2018

L van Winsen

3

1 reference

13 January 2018

G J van Kamp

4

1 reference

13 January 2018

F Barkhof

5

1 reference

13 January 2018

C H Polman

6

1 reference

13 January 2018

B M J Uitdehaag

7

1 reference

13 January 2018

publication date

1 June 2004

1 reference

13 January 2018

Multiple Sclerosis Journal

published in

1 reference

13 January 2018

volume

10

1 reference

13 January 2018

issue

3

1 reference

13 January 2018

page(s)

272-277

1 reference

13 January 2018

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E and the CNS response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Genomewide scan of multiple sclerosis in Finnish multiplex families

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

A full genome search in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

APOE genotype is a major predictor of long-term progression of disability in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Optimizing the association between disability and biological markers in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

10.1191/1352458504MS1010OA

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018